A woman in her 40s presented with a one month history of swelling and tenderness of the ears (fig 1), along with pain in her palms and fingers, and mild chest tightness. She had no history of chronic ...

Sarcoidosis is a systemic inflammatory disorder of unknown etiology, characterized by the formation of noncaseating granulomas, multisystem involvement, intrathoracic (pulmonary and lymph node ...

In a study led by a multinational team of experts, researchers at National Jewish Health and their collaborators in Colorado, ...

Chronic obstructive pulmonary disease (COPD) is the fourth leading cause of death in the United States, most often caused by ...

As the effects of wildfires persist in several parts of the United States, McGowan highlighted a public health alert ...

Abortion bans have affected US pulmonary and critical care physicians, resulting in care delays and restrictions, especially for low-income patients.

The US remains the largest pulmonary sarcoidosis market, both in terms of patient pool and market value. This dominance is attributed to higher diagnosis rates, advanced healthcare infrastructure ...

Topline data from Phase 3 EFZO-FIT™ study of efzofitimod in pulmonary sarcoidosis on track for the third quarter of 2025.

“As a sarcoidosis patient and storyteller, I've heard firsthand how this disease frustrates and isolates people. FSR is moving the needle in awareness and research. I hope to guide the ...